Prof. Tony Heagerty

Tony Heagerty is Professor of Medicine and Cardiac Centre Lead in the Institute of Cardiovascular Sciences at the University of Manchester. He has supervised Nuffield students for the past 5 years.

"I believe that the Nuffield Scheme is an outstanding way to reach out to students in the first instance, give them experience in science and at the same time encourage them into science based careers."

Where research placements take place: Core Technology Facility, The University of Manchester

Website: www.cardiovascular.manchester.ac.uk

What type of projects do you run?

Our projects are laboratory based investigating small artery and function in patients with diabetes and obesity and seeking to understand the effects of the fat is around these blood vessels on the way that arteries contract and relax.

What motivated you to supervise a school student through the Nuffield Research Placements scheme?

I believe that students should be motivated to look towards careers either in Medicine or in science based subjects and I hope to stimulate their research interests in these fields.

What do you feel are the main benefits to your organisation to taking on a Nuffield student?

The main benefit to our organisation is reaching out to the public in terms of showing what we do and engaging them in trying to improve the health of the nation.

What do you feel are the main benefits for students from taking part in the scheme?

Nuffield students are often enthusiastic. They contribute to our team and at the same time gain experience which is I hope helpful in choosing their career options later in life.

Would you recommend the scheme to others?

Of course

What personal skills would you say members of your team gained from supervising a Nuffield student?

All of the students are of high calibre and contribute greatly to the team ethos which is so imperative to successful research.

Has it helped communicate your area of science to a wider public, and why do you feel this is important?

I sincerely hope that this is the case.  As I said already I feel it is important that the public understands that there is much to do in terms of understanding common diseases and trying to improve their treatment.